Hypercalcaemia, parathyroid hormone-related protein and malignancy

Bayne, M.C. and Illidge, T.M. (2001) Hypercalcaemia, parathyroid hormone-related protein and malignancy. Clinical Oncology, 13, (5), 372-377. (doi:10.1053/clon.2001.9293).


Full text not available from this repository.

Original Publication URL: http://dx.doi.org/10.1053/clon.2001.9293


Hypercalcaemia is the most common serious metabolic complication of malignancy. Recent advances have significantly increased our understanding of the pathophysiology of hypercalcaemia of malignancy and revealed the importance of parathyroid hormone-related protein (PTHrP) in a wide range of physiological and pathological processes. This review examines the pathophysiology of hypercalcaemia of malignancy, focusing on the role of PTHrP before discussing further pathological and physiological processes in which PTHrP may be implicated, and the impact of this knowledge on the management of malignant disease.

Item Type: Article
Digital Object Identifier (DOI): doi:10.1053/clon.2001.9293
Related URLs:
Keywords: bisphosphonates, bone metastasis, hypercalcaemia, parathyroid hormone-related protein
Subjects: R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Divisions : University Structure - Pre August 2011 > School of Medicine > Cancer Sciences
ePrint ID: 26217
Accepted Date and Publication Date:
Date Deposited: 24 Apr 2006
Last Modified: 31 Mar 2016 11:49
URI: http://eprints.soton.ac.uk/id/eprint/26217

Actions (login required)

View Item View Item